Electromechanical interrelations during dobutamine stress in normal subjects and patients with coronary artery

A M Duncan1, C A O'Sullivan, D G Gibson

  • 1Department of Echocardiography, The Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK.

Insights

Altered ventricular activation during dobutamine stress impacts left ventricular function differently in healthy individuals and coronary artery disease patients. Echocardiography and ECG distinguish activation effects from the inotropic response.

Area of Science:

  • Cardiology
  • Physiology
  • Diagnostic Imaging

Background:

  • Dobutamine stress testing is used to assess left ventricular function.
  • Ventricular activation and inotropic state can influence cardiac performance.
  • Distinguishing these effects is crucial for accurate diagnosis.

Purpose of the Study:

  • To investigate the effects of altered ventricular activation during dobutamine stress on left ventricular function.
  • To differentiate these effects from the inotropic response in normal subjects and CAD patients.

Main Methods:

  • Prospective analysis of 12-lead ECG and echocardiography at rest and peak stress.
  • Doppler echocardiography assessed left ventricular ejection and filling patterns.
  • Correlated activation effects with ejection/filling times and Z ratio; measured inotropic response via peak aortic acceleration.

Main Results:

  • In controls, QRS shortened, Z ratio increased, and peak aortic acceleration (PAA) rose significantly.
  • In CAD patients, QRS lengthened, Z ratio decreased, but PAA still increased.
  • Changes in ejection and filling times reflected ventricular activation, independent of inotropic state.

Conclusions:

  • Relative ejection and filling times indicate ventricular activation during dobutamine stress, irrespective of inotropic changes.
  • Peak aortic acceleration reflects dobutamine's positive inotropic effect, independent of activation alterations.
Abstract

Related Concept Videos

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...